| 000 | 01593 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515034447.0 | ||
| 264 | 0 | _c20070810 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1093/annonc/mdl175 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCruz, J J | |
| 245 | 0 | 0 |
_aTargeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cMar 2007 |
||
| 300 |
_a421-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aOcaña, A | |
| 700 | 1 | _aDel Barco, E | |
| 700 | 1 | _aPandiella, A | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 18 _gno. 3 _gp. 421-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdl175 _zAvailable from publisher's website |
| 999 |
_c16462550 _d16462550 |
||